April 29, 2022 News Headlines
- HANYS, members advocate in Washington, D.C.
- Spotlight on Gouverneur Skilled Nursing Facility
- HANYS’ annual conference returns, in person!
- Keep the momentum going, become a Registry Partner
- CDC updates treatment, information for high-risk COVID-19 outpatients
- CMS issues guidance on Transparency in Coverage regulations
HANYS, members advocate in Washington, D.C.
New York hospital and health system leaders joined HANYS at AHA’s annual meeting this week and met with Senate Majority Leader Charles Schumer and Sen. Kirsten Gillibrand. We discussed our federal priorities, including supporting and strengthening the healthcare workforce, fiscal relief and supportive funding for healthcare providers, and funding care transformation. HANYS appreciates our senators’ strong support and members’ continued advocacy!
Spotlight on Gouverneur Skilled Nursing Facility
Their UTI care bundle successfully reduced UTI rates among residents from 1.2% in 2020 to 0.4% in 2021. Learn more in our Member Spotlight.
HANYS’ annual conference returns, in person!
Engage in discussion-provoking sessions about workforce solutions and health equity and network with your statewide colleagues and industry experts. Register today to join us June 16 - 17.
Keep the momentum going, become a Registry Partner
National Donate Life Month is coming to a close, but HANYS’ advocacy for organ donation isn’t stopping. We’re encouraging members to become a Registry Partner with Donate Life New York State, allowing patients to enroll in the Donate Life Registry on your hospital’s website or patient portal.
CDC updates treatment, information for high-risk COVID-19 outpatients
The CDC Health Alert highlighted widely available and accessible treatment options for non-hospitalized COVID-19 patients and recommended against certain uses. Among those, systemic corticosteroids are not recommended to treat patients with mild to moderate COVID-19 who do not require supplemental oxygen; patients who are receiving dexamethasone or another corticosteroid for other indications should continue therapy for their underlying conditions as directed by their healthcare providers. Antibacterial therapy is not recommended for the treatment of COVID-19 in the absence of another indication.
CMS issues guidance on Transparency in Coverage regulations
The guidance addresses frequently asked questions on the regulations, which go into effect July 1, that require health plans to release machine-readable files of their in-network negotiated rates and out-of-network allowed amounts.